Back to search

National and Kapodistrian University of Athens

Κυτταρικές, σηματοδοτικές και μεταβολικές τροποποιήσεις στη λοίμωξη από τον ιό της ηπατίτιδας C: ταυτοποίηση κυτταρικών στόχων που εμπλέκονται στην ανάπτυξη/εξέλιξη ηπατικού καρκίνου

Abstract

dc:description

Hepatitis C is a viral disease with a global geographical distribution and is one of the most important public health problems. It is currently estimated that 58 million people are carriers of Hepatitis C virus (HCV). Chronicity is established in 60-80% of HCV-infected individuals, accompanied by an increased risk for cirrhosis development within the next 20 years. At least 2-7% of cirrhotic patients develop hepatocellular carcinoma (HCC) annually. Reprogramming of host lipid metabolism is crucial for the progression of HCV-induced liver disease even after treatment with direct-acting antivirals (DAAs) in cirrhotic patients. The angiopoietin-like proteins -3 and -4 (ANGPTL-3 and ANGPTL-4) are important regulators of the host lipid metabolism, as they increase plasma lipids through inhibition of lipoprotein (LPL), hepatic (HL) and endothelial (LIPG) lipases. The aim of this thesis was to investigate the interactions between ANGPTLs and HCV before and after DAAs treatment in vivo and in vitro, and to examine the contribution of ANGPTLs in the deregulation of host lipid metabolism and the establishment / progression of viral infection. Previous studies from our laboratory showed a significant decrease in ANGPTL-3 gene expression during HCV infection in vitro. To investigate this phenomenon in depth, we constructed hepatic cell lines overexpressing both ANGPTL-3 and ANGPTL-4, in order to delineate possible ANGPTL-mediated mechanisms of viral infection inhibition. Specifically, we investigated the effects of ANGPTL overexpression on the host lipid metabolism and any putative influence exerted on the viral life cycle. Our results showed that under conditions of ANGPTL overexpression, a partial inhibition of the enzymatic activity of hepatic lipase (HL) was observed, accompanied by a decrease in the endogenous levels of hepatic triglycerides, probably due to reduced lipid uptake from the liver through HL, as well as a decrease in the number of lipid droplets-triglyceride store, albeit at different levels, pronounced in the case of ANGPTL-3. In contrast to ANGPTL-4, infection of ANGPTL-3 cell line with the HCV-2a and HCV-3a viral strains failed to reverse the observed decreases in the tested parameters of hepatic lipid metabolism, although HCV has been shown to increase hepatic lipogenesis. Notably, HCV viral replication was found to be significantly reduced upon ANGPTL-3 overexpression, but recovered following exogenous administration of recombinant apolipoprotein E (apoE). Subsequently, we investigated the expression of the ANGPTLs in HCV clinical samples throughout the natural progression of HCV infection and in long-term infections in vitro, before and after treatment with DAAs. ANGPTL-3 levels were found to be statistically reduced in HCV patients with advanced fibrosis, as compared to other disease stages, while ANGPTL-4 levels were progressively increased from acute infection to cirrhosis and HCC. In vitro experiments showed that only ANGPTL-3 mRNA was down-regulated during early infection, while both ANGPTLs were increased later. Treatment with DAAs did not alter ANGPTL-3 levels in advanced fibrosis/cirrhosis and in the in vitro HCV clearance model, which we developed in the laboratory, in contrast to ANGPTL-4. Finally, we observed a correlation between the key profibrotic factor TGF-β and ANGPTLs that strengthens the observed reciprocal relationship between ANGPTLs and hepatic fibrosis. Overall, we observed differential expression of the ANGPTL-3 and ANGPTL-4 lipid regulators during HCV infection and treatment. In fact, ANGPTL-3 appears to be part of the “molecular fingerprint” left by HCV after its DAA-mediated eradication that could contribute to persistent dysregulation of lipid metabolism in “cured” individuals and predispose to HCC development. The identification of such mechanisms helps to better understand the HCV life cycle and the pathobiology of HCV-associated liver disease and could potentially contribute to the development of innovative therapies.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Valiakou, Vaia
  • Βαλιάκου, Βαΐα

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57428

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Valiakou, Vaia; Βαλιάκου, Βαΐα. Κυτταρικές, σηματοδοτικές και μεταβολικές τροποποιήσεις στη λοίμωξη από τον ιό της ηπατίτιδας C: ταυτοποίηση κυτταρικών στόχων που εμπλέκονται στην ανάπτυξη/εξέλιξη ηπατικού καρκίνου. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/57428